Product Catalog[{"id":"459","name":"Evaluation of Parsaclisib plus Ruxolitinib in patients with Myelofibrosis who have not responded to Ruxolitinib alone","price":1,"sku":"myelofibrosis-trial-1","brand":false,"position":1,"category":"Medicines\/Haematology"},{"id":"446","name":"Ryplazim ","price":1,"sku":"Ryplazim (plasminogen, human-tvmh)","brand":false,"position":2,"category":"Medicines\/Haematology"},{"id":"441","name":"Mircera","price":1,"sku":"Mircera (methoxy polyethylene glycol-epoetin beta)","brand":"Roche Registration Limited","position":3,"category":"Medicines\/Haematology"},{"id":"439","name":"Ultomiris","price":1,"sku":"Ultomiris (ravulizumab)","brand":"Alexion Pharmaceuticals","position":4,"category":"Medicines\/Haematology"},{"id":"414","name":"Reblozyl","price":2168.6,"sku":"Reblozyl (luspatercept)","brand":"Bristol-Myers Squibb","position":5,"category":"Medicines\/Haematology"},{"id":"405","name":"Adakveo","price":2252.89,"sku":"Adakveo (crizanlizumab)","brand":"Novartis","position":6,"category":"Medicines\/Haematology"},{"id":"380","name":"Feraccru","price":103.48,"sku":"Feraccru (ferric maltol)","brand":"Shield Therapeutics","position":7,"category":"Medicines\/Haematology"},{"id":"379","name":"Accrufer","price":1,"sku":"Accrufer (ferric maltol)","brand":"Shield Therapeutics","position":8,"category":"Medicines\/Haematology"},{"id":"376","name":"Ondexxya","price":20055.75,"sku":"Ondexxya (andexanet alfa)","brand":"Alexion Pharmaceuticals","position":9,"category":"Medicines\/Haematology"}]
